Ostarine + raloxifene

Ostarine + raloxifene has been studied in 4 papers since 2022: none in people yet, 4 in animals; 1 in the past year. The research so far is in animals. The newest paper, Aug 25, 2026: “Improvement of Bone Healing by Combined Treatment with Selective Androgen and Estrogen Receptor Modulators in Female and Male Rats”.

Intervention

4 papers study it8 findingsUpdated

PubChemPubChemChEBI

See all 4 papers on ostarine + raloxifene

At a glance

The findings reach mice, none yet in people. 1 lab in 1 country.

None of its findings points the other way.

Mice: a single group. Cells, worms or flies and humans: nothing yet.
  • 1 lab in 1 country
  • Funders: Deutsche Forschungsgemeinschaft and 1 more
  • Animals4

What did studies of ostarine + raloxifene find?

8

Studies of ostarine + raloxifene measured 8 outcomes, among them bone volume fraction, biomechanical properties and luteinizing hormone.

Bone volume fraction

upin rats1

1 study
  1. Ostarine + raloxifene increases bone volume fraction in ovariectomized or orchiectomized rats with osteotomy.

    “Increased total, callus, and cortical densities as well as bone volume fraction were observed in the Ost + Ral group”

    Animalsin ovariectomized or orchiectomized rats with osteotomy

    Improvement of Bone Healing by Combined Treatment with Selective Androgen and Estrogen Receptor Modulators in Female and Male Rats

    Calcified tissue international

Biomechanical properties

upin rats1

1 study
  1. Ostarine + raloxifene improves biomechanical properties in ovariectomized or orchiectomized rats with osteotomy.

    “Biomechanical properties were improved in the Ral and Ost + Ral groups relative to Ovx/Orx controls.”

    Animalsin ovariectomized or orchiectomized rats with osteotomy

    Improvement of Bone Healing by Combined Treatment with Selective Androgen and Estrogen Receptor Modulators in Female and Male Rats

    Calcified tissue international

Luteinizing hormone

upin rats1

1 study
  1. Ostarine + raloxifene increases luteinizing hormone in rats (ovariectomized rats).

    “Conversely, the combined treatment increased serum phosphorus and luteinizing hormone levels”

    Animalsovariectomized ratsserumup to 13 weeksfemales

    Effects of Combined Treatment With Selective Androgen and Estrogen Receptor Modulators Ostarine and Raloxifen on Bone Tissue In Ovariectomized Rats

    Calcified tissue international

More on Luteinizing hormone

Serum magnesium

downin rats1

1 study
  1. Ostarine + raloxifene decreases serum magnesium in rats (ovariectomized rats).

    “Conversely, the combined treatment increased serum phosphorus and luteinizing hormone levels, decreased serum magnesium and calcium”

    Animalsovariectomized ratsserumup to 13 weeksfemales

    Effects of Combined Treatment With Selective Androgen and Estrogen Receptor Modulators Ostarine and Raloxifen on Bone Tissue In Ovariectomized Rats

    Calcified tissue international

More on Serum magnesium

Structural and biomechanical bone parameters

upin rats1

1 study
  1. Ostarine + raloxifene improves structural and biomechanical bone parameters in rats (ovariectomized rats).

    “OST + RAL treatment showed a favorable effect on structural and biomechanical bone parameters”

    Animalsovariectomized ratsboneup to 13 weeksfemales

    Effects of Combined Treatment With Selective Androgen and Estrogen Receptor Modulators Ostarine and Raloxifen on Bone Tissue In Ovariectomized Rats

    Calcified tissue international

Muscle weight

downin rats1

1 study
  1. Ostarine + raloxifene decreases muscle weight in ovariectomized rats.

    “OST + RAL increased muscle nucleus ratio, uterine weight, serum phosphorus, FSH and luteinizing hormone and decreased body and muscle weight, serum calcium.”

    Animalsin ovariectomized ratsskeletal musclethirteen weeks

    Advantage of ostarine over raloxifene and their combined treatments for muscle of estrogen-deficient rats

    Journal of endocrinological investigation

Prostate androgenic effect

downin rats1

1 study
  1. Ostarine + raloxifene decreases prostate androgenic effect in rats (combined treatment in orchiectomized rats).

    “OST + RAL-P had an anabolic impact on muscle, reduced androgenic effect on the prostate, and normalized food intake.”

    Animalscombined treatment in orchiectomized ratsprostateweeks 0-18

    Combination of selective androgen and estrogen receptor modulators in orchiectomized rats

    Journal of endocrinological investigation

Muscle anabolism

upin rats1

1 study
  1. Ostarine + raloxifene increases muscle anabolism in rats (combined treatment in orchiectomized rats).

    “OST + RAL-P had an anabolic impact on muscle, reduced androgenic effect on the prostate, and normalized food intake.”

    Animalscombined treatment in orchiectomized ratsmuscleweeks 0-18

    Combination of selective androgen and estrogen receptor modulators in orchiectomized rats

    Journal of endocrinological investigation

Latest

Dec 2025: 0Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 1Sep 2026: 0Oct 2026: 0Nov 2026: 01 paper in 12 months